2-keto-3-deoxyoctonate

Subscribe to Selected New Research on 2-keto-3-deoxyoctonate

5 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Also Known As:

(D-manno)-isomer of 2-keto-3-deoxyoctonate; 2-keto-3-deoxy-D-manno-octonic acid; 2-keto-3-deoxyoctulosonic acid; 3-KDO; 3-deoxy-2-octulosonic acid; 3-deoxy-D-manno-octulosonic acid; 3-deoxy-D-mannoctulosonate; 3-deoxy-D-mannooctulosonate; 3-deoxy-alpha-D-manno-2-octulosonic acid; KDO cpd; ion(1-),(D)-isomer of 2-keto-3-deoxyoctonate; 3-deoxyoctulosonic acid

Bio-Agent Context: Research Results

Organic Chemicals: 40

Carboxylic Acids: 63

Hydroxy Acids: 20

Sugar Acids: 1

2-keto-3-deoxyoctonate: 5

Acyclic Acids

Sugar Acids: 1

2-keto-3-deoxyoctonate: 5

Carbohydrates: 2945

Sugar Acids: 1

2-keto-3-deoxyoctonate: 5

Related Diseases

1.	Shwartzman Phenomenon (Shwartzman Reaction) 02/01/1982 - "Neither 2-keto-3-deoxyoctonate nor heptose was detected, and the antigen did not induce a Shwartzman reaction" Get all the results and reference details, order at left...
2.	Periodontal Pocket (Periodontal Pockets) 03/01/1986 - "Pure lipopolysaccharide extracted from Selenomonas spp. isolated from human periodontal pockets was composed of 23.7% carbohydrate, 16.5% hexosamine, 1.2% 2-keto-3-deoxyoctonate, 0.7% heptose, 26.0% lipid, 1.8% protein, and 1.3% phosphorus" Get all the results and reference details, order at left...
3.	Neoplasms (Cancer) 05/01/1983 - "Toxicity and tumor-regressive potency were retained after removal of 2-keto-3-deoxyoctonate (KDO) by exposing the glycolipids to sodium acetate solution at pH 4.5" Get all the results and reference details, order at left...
4.	Legionnaires' Disease (Legionnaire's Disease) 04/01/1979 - "The antigen was composed of 35% carbohydrate, 2.6% protein, 1.8% phospholipid, and 1% 2-keto-3-deoxyoctonate and was important in the host's antibody response because it inhibited the indirect immunofluorescent and microagglutination titers of convalescent sera from patients with Legionnaires' disease" Get all the results and reference details, order at left...
5.	Hemolysis 07/17/1978 - "Comparative chemical analysis (methylation, gas chromatography/mass spectrometry, periodate oxidation, etc.) of the lipopolysaccharides and degraded polysaccharides derived from Shigella sonnei phase I, phase II and galactose-deficient R mutants revealed a structure as shown: (formula: see text) 3-Deoxy-D-manno-octulosonic acid (dOclA) as an immunodeterminant was observed in the passive hemolysis inhibition test by (a) selective inhibition of the phase II system by dOclA; (b) the kinetics of the change of serological activity during mild acid treatment: 1% acetic acid abolished serological activity; (c) a lack of activity in galactose-less R mutants and reactivity with Re mutants including Salmonella minnesota Re" Get all the results and reference details, order at left...
5 Diseases and 5 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Antigens
2.	Sodium Acetate (Sodium Acetate, Anhydrous)
3.	Acetic Acid (Vinegar)
4.	Polysaccharides
5.	Phosphorus (Red Phosphorus)
6.	Lipopolysaccharides
7.	Glycolipids
8.	Galactose (Galactopyranose)
9.	metaperiodate (periodate)
9 Drugs and Important Bio-Agents and 5 more articles analyzed in the Research Interface, order at left...

Research Interface Subscription

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Searches
2 clicks from Disease to Drug to Evidence
Trial references
All the Positive Outcomes
Drug and Therapy searches
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>